c-Lecta

Executive Summary

c-Lecta is a German biotechnology company specializing in the development, production, and distribution of enzyme products for the food, feed, beverage, and pharmaceutical industries. Founded in 2022 as part of the Kerry Group, it operates the Kerry Biotechnology Centre in Leipzig, leveraging over 20 years of enzyme engineering expertise. The company serves over 400 customers in more than 40 countries, offering biotechnological solutions that improve process efficiency, product quality, and sustainability. With a strong focus on innovation and a diverse product portfolio, c-Lecta is well-positioned to capitalize on the growing demand for enzymes in industrial applications. Its integration within Kerry Group provides access to global distribution networks and R&D resources, enhancing its competitive edge in the rapidly evolving synthetic biology and biologics markets.

Upcoming Catalysts (preview)

• Q3 2026Launch of novel enzyme for pharmaceutical applications60% success
• Q4 2026Expansion into Asian markets via strategic partnerships50% success
• TBDAnnouncement of patent approvals for key enzyme engineering technologies70% success